Active Ingredient(s): Droperidol
FDA Approved: * June 11, 1970
Pharm Company: * AKORN
Category: Antipsychotic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Inapsine Overview

Droperidol /droprIdl/ (Inapsine, Droleptan, Dridol, Xomolix, Innovar [combination with fentanyl]) is an antidopaminergic drug used as an antiemetic (that is, to prevent or treat nausea) and as an antipsychotic. Droperidol is also often used as a sedative in intensive-care treatment. Contents 1 History 2 Medical use 3 Black box warning 4 Side effects 5 Chemistry 6 References 7 Further reading History Discovered at Janssen Pharmaceutica in 1961, droperidol is a butyrophenone which acts a...

Read more Inapsine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Inapsine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 2.5mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Inapsine: (2 results)

Sorted by National Drug Code
  • 17478-010 Inapsine 2.5 mg/ml Intramuscular; Intravenous Injection by Akorn, Inc.
  • 17478-531 Inapsine 2.5 mg/ml Intramuscular; Intravenous Injection by Akorn, Inc.

Other drugs which contain Droperidol or a similar ingredient: (1 result)